Given that the majority of our patients were those with chronic hepatitis B-induced HCC, similar to the other 2 reports13,35, it implied that the role of DDX5 was likely to be tumor- and patient-specific, rather than those of underlying liver diseases. The gene discussed is DDX5; the disease is hepatocellular carcinoma.